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ypoplastic Left Heart
yndrome
t Is All in the Genes*
aul D. Grossfeld, MD
an Diego, California
n 1851, the German pathologist Barbedelan reported the
utopsy findings of a 6-month-old infant who died from
evere asphyxia (1). Evaluation of the cardiac anatomy
evealed hypoplasia of the left ventricular cavity without
ommunication to the aorta, severe hypoplasia of the as-
ending aorta, and a ductus arteriosus. Barbedelan hypoth-
sized that the systemic circulation was dependent on
atency of the ductus arteriosus.
One hundred years later, Lev (2) published the first
eport in the English literature of an infant with hypoplasia
f the left sided structures, similar to those described by
arbedelan. In 1958, Noonan and Nadas (3) published a
eries of 101 patients with hypoplasia of the left heart
tructures and proposed the term hypoplastic left heart
yndrome (HLHS). Currently, HLHS is conventionally
efined as hypoplasia of the left ventricular chamber, ste-
osis and/or atresia of the mitral and aortic valves, and
ypoplasia of the aorta.
See page 1590
Despite remarkable advances in the clinical care of
LHS, this defect remains one of the most challenging and
east-understood forms of congenital heart disease. During
he last 50 years, there have been increasing reports sup-
orting a genetic etiology for HLHS (4): numerous cases
ave been reported describing HLHS in siblings, including
wins. Several specific chromosomal disorders have been
ssociated with an increased frequency of HLHS, and there
s a high frequency of extracardiac defects associated with
LHS. Most recently, 2 studies have identified an in-
reased frequency of congenital heart defects in relatives of
atients with HLHS (5,6).
Most forms of inheritance have been described, including
utosomal-dominant, autosomal-recessive, and X-linked.
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.v
From the Division of Pediatric Cardiology, University of California, San Diego
chool of Medicine, San Diego, California.espite this, some investigators have proposed that HLHS
s multifactorial, placing a lesser role on a sole genetic
tiology (7). To date there are no genetically engineered
nimal models for HLHS.
In this issue of the Journal, Hinton et al. (8) performed a
omprehensive statistical analysis on 38 families of infants
ith HLHS to determine the heritability component of
LHS. They concluded that HLHS was almost exclusively
he result of a genetic cause. Fifty-five percent of the
amilies had more than 1 affected family member. The
ecurrence rate for HLHS among siblings was 8%. Twenty-
wo percent of siblings had another cardiovascular malfor-
ation (CVM). If a parent had a CVM, 21% of siblings had
LHS, and 26% had another CVM. Overall, the recur-
ence rate of HLHS in siblings was 515-fold greater than
hat of the general population, and 1,050-fold higher when
parent had a CVM. Taken together, HLHS has one of the
trongest genetic components of any congenital heart defect.
The clinical implications of a genetic etiology for HLHS
re substantial. On the basis of the high frequency of
rst-degree relatives with heart defects, all first-degree
elatives should have a baseline echocardiogram. Second,
ecause of the high recurrence rate of CVMs, and in
articular HLHS, a detailed fetal echocardiogram should be
erformed by a pediatric cardiologist on subsequent fetuses
n families with a previous child with HLHS. Third, on the
asis of the findings of Hinton and previous recent studies,
mproved genetic counseling can be offered to all families
ith a child with HLHS.
Although significant advances have been made in the
linical care of patients with HLHS, our understanding of
he underlying molecular and genetic mechanisms of
LHS is limited. In 1970, Harh et al. (9) reported the
evelopment of a chick model for HLHS. Recently,
eAlmeida et al. (10) demonstrated that ligation of the left
trium in the chick, which decreased prograde blood flow to
he left ventricle, caused left ventricular hypoplasia in
ssociation with cardiac myocyte hypoplasia. Importantly,
hey demonstrated that increasing prograde flow to the left
ide of the heart resulted in a “hemodynamic rescue” of the
LHS phenotype.
It is likely that at least some cases of HLHS are due to
enetically predisposed decreased inflow to the developing
eft heart. In the current study, Hinton et al. (8) demon-
trated that in virtually all cases of HLHS, the aortic and
itral valves were abnormal. They also frequently found
bnormalities in the tricuspid and pulmonary valves. These
bservations suggest that, in the majority of patients,
LHS may be due to a primary defect in valve develop-
ent, leading to hypoplasia of the left-sided structures.
lternatively, some forms of HLHS may be due to a
rimary defect in left ventricular development. For example,
n some patients with critical aortic stenosis, relief of aortic
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October 16, 2007:1596–7 Editorial CommentTo date, putative mutations in only a few genes have been
dentified in association with HLHS patients: Connexin43
12) and NKX2.5 (13,14). Connexin43 is a cardiac gap
unction protein that is critical for heart development.
utations in the cardiac transcription factor NKX2.5 have
een identified in a small number of patients with HLHS.
ost recently, mutations in NOTCH-1 were identified in
families with left-sided heart defects, most commonly
ortic valve defects (15). One family member had a variant
f HLHS. Overall, mutations in these 3 genes comprise a
ery small subset of patients with HLHS, consistent with
ultiple causative genes for HLHS.
Clearly, most of the disease-causing genes for HLHS
emain to be identified. Significant challenges lie ahead as
nvestigators move toward the identification of new genes
or HLHS. First, the number of genes likely to cause
LHS and the paucity of kindreds with a large number of
ffected individuals makes linkage studies difficult. Second,
t least in some cases there is incomplete penetrance for
LHS (see discussion to follow). Consequently, potential
isease-causing mutations in affected individuals also may
e identified in the normal control population, thereby
aking it difficult to prove causality for a candidate gene.
Many interesting questions persist: 1) Will most of the
enes that cause HLHS be involved in valve development,
r could they be involved in other aspects of heart develop-
ent (e.g., left ventricular development)? 2) What is the
asis for the phenotypic variability in families with left-
ided heart defects? That is, what determines whether a
enetically predisposed individual develops a relatively mild
efect such as bicuspid aortic valve, versus the most severe
efect, HLHS? 3) What factors determine incomplete
enetrance for some cases of HLHS? For example, in the
1q terminal deletion disorder (Jacobsen syndrome), in
hich 10% of infants are born with HLHS (16), 2 patients
ith the identical deletion had completely different cardiac
henotypes: a normal heart in 1 and HLHS in the other.
dentification of these genetic and/or environmental mod-
fiers should give important additional insights into the
echanisms underlying HLHS.
Despite the formidable challenges, there is cause for opti-
ism. Using a similar approach, Hinton et al. (8) determined
reviously that a bicuspid aortic valve has a strong genetic
omponent (17). They were able to subsequently identify 3
hromosomal loci that may contain disease-causing genes for
icuspid aortic valve (18). For deletion disorders, recent tech-
ical advances allow breakpoint mapping to be performed to
ingle gene resolution. Consequently, potential “critical re-
ions” can be defined with unprecedented resolution, which
hould facilitate the identification of candidate genes.
Undoubtedly, studies such as those of Hinton et al. (8)
ill not only help improve genetic counseling for patients
ith HLHS but also reinforce and validate the importance
f efforts to identify new genes for HLHS. Identification of
ew genes that cause HLHS and the development of
enetically engineered animal models for HLHS is certaino bolster our understanding of this devastating form of
ongenital heart disease, as well as the other more common
ut less severe left-sided cardiac defects.
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